Rachel Lehamann-Haupt bio head shot image

Rachel Lehmann-Haupt

The Orphan Drug Revolution takes on treatments of rare diseases

Developing therapies for patients with rare diseases: a career in the Orphan Drug Revolution by Jim Geraghty, JD, MS.

Starting a Revolution in Treating Rare Diseases

Laurie Glimcher

What's Needs to Happen to Accelerate Cancer Research and Improve Care?

Gillian Sandler is a life sciences investor who funds health tech companies that could potentially help millions of people. But her journey began with a simple desire: To find a treatment for her own sister’s autoimmune disease.

How a Passionate Investor Battles Auto-Immunity

How a Passionate Investor Battles Autoimmunity Disease

Mary Woolley

What Will It Take to Maintain America’s Leadership in Research and Technology?

Frank Discussion about Rare Diseases

Why Rare Diseases are Really Not So Rare — and What We Can Learn From Those Living with Them

Stories

345 Park Avenue South

Book a space

Xchange Challenge

Where scientists, entrepreneurs and visionaries converge.

Campus

Cure Ecosystem

Space Availability

Event Spaces

Gallery

A place to *Thrive*

Green

All floors are lab-ready and cabled for digital health.

Residency

Cure Residents

Be part of *Cure.*

Orange

XSeed Award

Tuesday Talks

Joe Wilson How Life Sciences Companies Use AI to Target Investors Mega Menu Image 

How Life Science Companies Use AI to Target Investors

Events

Upcoming Events

Past Events

Speakers

Cure *Events.*

Magenta

Partner with us

Contact us

Cure Opens Xseed Award Applications to Support Underfunded and Underrepresented NYC Life Science Startups With Up to $500,000

A place to Thrive

Where scientists, entrepreneurs and visionaries converge.

Be part of Cure.

All floors are lab-ready and cabled for digital health.

Cure Events.

How Life Science Companies Use AI to Target Investors

A place to Thrive

Where scientists, entrepreneurs and visionaries converge.

Be part of Cure.

All floors are lab-ready and cabled for digital health.

Cure Events.

How Life Science Companies Use AI to Target Investors

Cure Events.